Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Bio-Rad Laboratories, Inc.

The latest update is out from Xenetic Biosciences ( ($XBIO) ). On September 23, 2026, Xenetic Biosciences released an updated investor presentation...

Xenetic Updates Investors on Santersus Share Exchange Plans

BIotrend Cevre ve EnerjI Yatirimlari AS ( ($TR:BIOEN) ) has provided an update. Biotrend Cevre ve Enerji Yatirimlari AS, active in renewable energy...

Biotrend Reassures Investors Amid Market Volatility and Regulatory Changes

An announcement from Valion Bio ( ($VBIO) ) is now available. On September 22, 2026, Valion Bio appointed board member and life sciences veteran De...

Valion Bio Names Interim CEO Amid Governance Reshuffle

Biome Australia Ltd ( ($AU:BIO) ) has issued an update. Biome Australia has released its updated corporate governance statement for the financial y...

Biome Australia Files Updated Corporate Governance Statement and Appendix 4G

Biome Australia Ltd ( ($AU:BIO) ) has issued an update. Biome Australia Ltd has built two complementary therapeutic platforms featuring innovative ...

Biome Australia Expands Evidence-Based Microbiome Therapeutic Platforms

In a report released today, Matthew Caufield from H.C. Wainwright maintained a Buy rating on Zenas BioPharma, Inc., with a price target of $44.00. ...

H.C. Wainwright Keeps Their Buy Rating on Zenas BioPharma, Inc. (ZBIO)

Bioceres Crop Solutions ( ($BIOX) ) has shared an update. On September 14, 2026, Bioceres Crop Solutions reported fiscal fourth-quarter revenues of...

Bioceres Wins Nasdaq Capital Market Transfer and Extra Time on Bid-Price Compliance

Bioceres Crop Solutions (($BIOX)) has held its Q4 earnings call. Read on for the main highlights of the call. Bioceres Crop Solutions’ latest earni...

Bioceres Crop Solutions Earnings Call: Margin-Focused Reset

An announcement from Ibio ( ($IBIO) ) is now available. In September 2026, iBio updated its corporate presentation to highlight a strategic focus o...

iBio Highlights Breakthrough Antibody Strategy for Obesity

In a report released today, from Wedbush maintained a Buy rating on Crescent Biopharma, with a price target of $27.00. Currently, the analyst conse...

Wedbush Remains a Buy on Crescent Biopharma (CBIO)

There’s a lot to be optimistic about in the NA sector as 3 analysts just weighed in on BioAge Labs, Inc. (BIOA), OS Therapies Incorporated (OSTX) a...

Analysts’ Top NA Picks: BioAge Labs, Inc. (BIOA), OS Therapies Incorporated (OSTX)

An announcement from BioVersys AG ( ($CH:BIOV) ) is now available. BioVersys reported solid progress across its clinical pipeline in the first half...

BioVersys Advances Late-Stage Antibiotic Pipeline and Extends Funding Runway to 2028

An announcement from Orchestra BioMed Holdings ( ($OBIO) ) is now available. In September 2026, Orchestra BioMed released a corporate slide present...

Orchestra BioMed Highlights Pivotal Cardiovascular Program Progress

Biosynex SA ( ($FR:ALBIO) ) has shared an announcement. Biosynex SA has entered safeguard proceedings in Strasbourg, aiming to optimize its financi...

Biosynex Creditors Vote on Safeguard Plan Restructuring €81.8m in Liabilities

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achieve Life Sciences (ACHV) and Jade Biosciences (J...

Wall Street Analysts Are Bullish on Top Healthcare Picks

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Equillium (EQ) and Jade Biosciences (JBIO) with bull...

BioVersys AG ( ($CH:BIOV) ) has provided an update. BioVersys AG will present a corporate overview at the H.C. Wainwright 28th Annual Global Invest...

BioVersys Showcases MDR Antibiotic Pipeline at H.C. Wainwright Global Investment Conference

Biosynex SA ( ($FR:ALBIO) ) has provided an announcement. Biosynex announced that co-founder Thierry Paper has resigned from his roles as Deputy Ch...

Biosynex Co-Founder Thierry Paper Steps Down From Executive and Board Roles

Biomm SA ( ($BR:BIOM3) ) just unveiled an announcement. Biomm’s board of directors has approved a private issuance of unsecured, non-convertible de...

Biomm Secures R$88.3 Million Debenture Backstop from Alaska Investimentos

Swedish Orphan Biovitrum AB ( ($SE:SOBI) ) has provided an update. Sobi has completed a directed issue of 223,677 class C shares, subscribed in ful...

Sobi Completes Class C Share Issue to Fund Employee Incentive Programme

BIotrend Cevre ve EnerjI Yatirimlari AS ( ($TR:BIOEN) ) has provided an announcement. Trading in Biotrend’s BIOEN.E shares on Borsa Istanbul has be...

Biotrend Shares Enter Circuit Breaker Call Auction on Borsa Istanbul

In a report released today, Eliana Merle from Barclays maintained a Buy rating on BridgeBio Pharma, with a price target of $157.00. Merle covers th...

Barclays Sticks to Its Buy Rating for BridgeBio Pharma (BBIO)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (CYTK) and Ibio (IBIO) with bullish sen...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BIO	$387.54	+2.29%	367.34K
3
4
5

BIO

Get Bio-Rad Laboratories, Inc. Data in Excel

Get Bio-Rad Laboratories, Inc. Data in Excel